<DOC>
	<DOCNO>NCT01091337</DOCNO>
	<brief_summary>To compare efficacy safety inhale procaterol ( Meptin Air ) versus inhale salbutamol meter dose inhaler ( MDI ) reliever acute exacerbation asthma imminent respiratory failure .</brief_summary>
	<brief_title>Comparative Study Efficacy Safety Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer Management Acute Asthma Attack Emergency Room</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Procaterol</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Adult patient age 20 year old bring Emergency Room ( ER ) acute bronchospasm Diagnosed case bronchial asthma base history , physical examination pulmonary function test Patients maintain inhaled steroid active medical problem ( pulmonary TB , cardiac renal disease ) aside asthma Presence know risk factor asthma mortality disqualify patient study unless impend respiratory failure All patient must sign informed consent form Patients respiratory distress consistent severe exacerbation require intensive care hospital admission Who intake oral bronchodilator 6 hr prior consult Who intake oral steroid within last 24 hrs Those positive history allergy hypersensitivity procaterol salbutamol Patients diagnose clinically suspect COPD ( eversmokers &gt; 10 packyears smoke history expose workplace heavy smoke load ) Presence concurrent disease/diseases may aggravate asthma thereby delay bronchodilator response ( e.g. , pneumonia , pulmonary congestion others ) Patients medical condition serious enough warrant immediate concurrent therapy 1 hour study and/or whose condition adversely affect treatment give ( like uncontrolled diabetes , renal failure hepatic insufficiency ) The NIH Working Group Asthma Pregnancy recommend pregnant asthmatic treat aggressively nonpregnant patient particularly acute asthmatic attack . , Bronchodilators ( except epinephrine study ) find safe pregnancy risk class B C. For reason , pregnancy exclusion criterion study pregnancy test require childbearing age group . Requiring test unnecessarily delay treatment acute asthma . However , suspect suffering pregnancyrelated complication like vaginal bleeding , premature labor , preeclampsia others , exclude . Severe Acute Asthma Attack , reason patient exclusion , shall define study presence one follow criterion : 1 . Severe asthma lack response initial therapy emergency department worsen asthma despite adequate therapy . 2 . Presence confusion , drowsiness , sign impend respiratory arrest , loss consciousness 3 . WoodDowne 's clinical asthma score score &gt; 5 ( see table 2 ) Any patient currently participate drug trial and/or participate drug trial less 1 month termination trial exclude Patients previously participate study exclude</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>